Skip to main content

SenoBright™ HD Contrast-Enhanced Mammography - Mammography

Reference: 1641
Type: Capital Savings
Start Date: 2 November 2026
Expiry Date: 31 March 2027

In line with the forthcoming changes to the Breast Screening Guidelines, we are offering a 20% discount on GE HealthCare SenoBright™ HD Contrast-Enhanced Mammography (CESM).

SenoBright™, Contrast Enhanced Spectral Mammography (CESM) is an optional upgrade to your Pristina system and can be used as an alternative to breast MRI to enhance the breast care pathway. With high specificity and sensitivity you can reduce the number of unnecessary biopsies and surgeries.

The SenoBright™ HD CESM application shall enable contrast heightened breast imaging using a dual energy technique. This imaging technique can be used as an adjunct following mammography and ultrasound exams to localise a known or suspected lesion. SenoBright™ enables providers to see lesions using Contrast Enhanced Mammography (CEM) and sample with certainty.

SenoBright™ HD chooses filtering materials depending on the operating mode and the exposure levels necessary. For the high-energy acquisition, a proprietary multi-layer filter is used to shape the resulting energies of the X-ray spectrum to those
required to best highlight iodine. The system allows for high throughput: 30 CESM exams can be acquired over a typical eight-hour working day.

Features and Benefits

  • Helps reduce the masking effect of fibro glandular breast tissue and increases the tumour signal.
  • Contrast agent highlights areas of unusual blood flow.
  • CEM is an alternative imaging method to MRI, especially when MRI availability is limited, and for patients for whom MRI is contraindicated.
  • Find lesions that cannot be seen on routine mammography.
  • Provide high specificity for low false-positives.
  • With Nira, overall image quality was better assessed in more than 98% of the images presented by all the readers.
  • Expand to a large population of women who can access this technology for equitable care.
  • Reduce agonising wait time for women to get to a confident diagnosis.
  • Target the 43% of patients who would not come back for follow-up.

This offer is over and above the standard discount available through the NHS Supply Chain framework agreement. The discount is a fixed term offer. All orders must be placed before 31 March 2027.

For more information, please contact

Sarah Whittaker

Category Manager – Digital Mammography, DEXA and Lithotripsy

Carrwood Park

sarah.whittaker@supplychain.nhs.uk

07971 234 999

GE HealthCare SenoBright™ HD Contrast-Enhanced Mammography
GE Healthcare Logo